Rubraca^® (rucaparib) tablets is now owned by pharma& Schweiz GmbH

For questions outside of adverse event reporting, product complaints or medical information inquiries, please email contact@pharmaand.com.

For adverse event reporting, product complaints or medical information inquiries, please email pv@pharmaand.com.

For adverse event reporting, product complaints or medical information inquiries in the US, please contact:

Phone: 1-415-409-7220
Toll Free 1-844-258-7662
Email: medinfo@clovisoncology.com